#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myxoid liposarcoma Intracranial germ cell tumour Gastrointestinal disorder Dementia Postprandial hypoglycaemia Immune thrombocytopenia Lymphangiosarcoma Gastric cancer Albright's disease Retinal artery occlusion Adenovirus infection T-cell type acute leukaemia Lung adenocarcinoma Amyloidosis Acute respiratory distress syndrome More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Life with Disease Marginal zone lymphoma refractory Mitochondrial myopathy – Life with Disease Netherton’s syndrome – Life with Disease Glomerulonephritis rapidly progressive – Life with Disease Netherton’s syndrome – Trials in Disease Propionic acidaemia – Diagnostics Pleomorphic leiomyosarcoma – Treatment Fabry’s disease – Life with Disease Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Triglycerides, Medium Chain Sodium Phosphate Obexelimab Simeticone Rasagiline Lecanemab Bomedemstat Enalapril Fluorometholone Jnj-64042056 OSIMERTINIB MESYLATE Vibostolimab Dimeticone Histamine Hydrochloride Ferric Carboxymaltose GSKVX000000034796 Ofatumumab Pp1493 Fluoroethyltyrosine F-18 Methionine More therapies…

    Learn about Your Condition

    Ovarian cancer recurrent Hereditary optic atrophy Sarcoidosis Osteomyelitis acute Neonatal hyperglycaemia Clinically isolated syndrome Behavioural addiction Arteriovenous malformation Affective disorder Fallopian tube cancer Neoplasm Burning mouth syndrome Cardiac disorder Genital infection female Hypomagnesaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study to evaluate the efficacy and safety of zenagamtide in people with overweight or obesity and knee osteoarthritis

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    • Osteoarthritis
    Bulgaria Denmark Greece Italy Poland Spain

  • A study to evaluate the effects of zenagamtide in people with overweight or obesity and obstructive sleep apnoea not treated with positive airway pressure

    Recruiting

    3 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Denmark Germany Poland Spain

  • A study to evaluate the effectiveness and safety of eloralintide in adults with obesity or overweight without type 2 diabetes.

    Recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • LY3841136 SODIUM
    Belgium Germany Poland

  • Study of zenagamtide for weight loss and sleep improvement in patients with obesity and obstructive sleep apnea using positive airway pressure therapy

    Recruiting

    3 1
    Investigated Diseases:
    • Obstructive sleep apnoea syndrome
    Germany Poland Spain

  • Study of guselkumab and dietary changes for patients with recurring or difficult-to-treat pouchitis

    Recruiting

    3 1 1
    Investigated Diseases:
    • Pouchitis
    Investigated Drugs:
    • Guselkumab
    Belgium

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MAGNESIUM ACETATE TETRAHYDRATE
    • Magnesium Chloride Hexahydrate
    • Sodium Acetate Trihydrate
    Germany
Previous Page
1 2 3 4 5 6 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!